{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:39Z","timestamp":1786649739321,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To evaluate the clinical efficacy and safety of topical azithromycin 1% ophthalmic preparation in bacterial conjunctivitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A prospective observational study was conducted on 150 patients clinically diagnosed with bacterial conjunctivitis and treated with topical azithromycin 1%. Clinical response and adverse events were assessed during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>High clinical cure rates were observed with minimal adverse effects, indicating good efficacy and tolerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Topical azithromycin 1% is a safe and effective treatment option for bacterial conjunctivitis in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_1757_25","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:00:15Z","timestamp":1773309615000},"page":"16-18","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Azithromycin 1% in the Clinical Management of Bacterial Conjunctivitis"],"prefix":"10.4103","volume":"18","author":[{"given":"Apurva H.","family":"Suthar","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, GMERS Medical College, Vadnagar, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"R1-20260416","first-page":"CD001211","article-title":"Antibiotics versus placebo for acute bacterial conjunctivitis","volume":"6","author":"Sheikh","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20260416","first-page":"105","article-title":"Monitoring antibiotic resistance in ocular microorganisms: Results from the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study","volume":"211","author":"Haas","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R3-20260416","first-page":"1221","article-title":"Review of topical antibiotics for ophthalmic use","volume":"14","author":"Scoper","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R4-20260416","first-page":"254","article-title":"Anti-inflammatory effects of azithromycin on the ocular surface","volume":"18","author":"Sadrai","year":"2020","journal-title":"Ocul Surf"},{"key":"R5-20260416","first-page":"822","article-title":"Phase III evaluation of azithromycin ophthalmic solution in bacterial conjunctivitis","volume":"126","author":"Hwang","year":"2019","journal-title":"Ophthalmology"},{"key":"R6-20260416","first-page":"1951","article-title":"Safety considerations in topical ophthalmic antibiotic therapy","volume":"14","author":"Fiscella","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"R7-20260416","first-page":"1189","article-title":"Bacterial conjunctivitis in developing countries: Epidemiology and management challenges","volume":"105","author":"Sharma","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R8-20260416","first-page":"1298","article-title":"Clinical profile and treatment outcomes of bacterial conjunctivitis in North India","volume":"70","author":"Kaur","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"R9-20260416","first-page":"259","article-title":"The dilemma of bacterial conjunctivitis treatment","volume":"141","author":"Ung","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2023.12.041","article-title":"Preferred practice pattern: Conjunctivitis","volume":"131","year":"2024","journal-title":"Ophthalmology"},{"key":"R11-20260416","first-page":"2384","article-title":"Clinical cure of bacterial conjunctivitis with azithromycin ophthalmic solution","volume":"37","author":"Abelson","year":"2020","journal-title":"Adv Ther"},{"key":"R12-20260416","first-page":"1123","article-title":"Pharmacokinetics and tissue penetration of topical azithromycin in ocular infections","volume":"46","author":"Luchs","year":"2021","journal-title":"Curr Eye Res"},{"key":"R13-20260416","first-page":"3579","article-title":"Comparison of topical azithromycin and fluoroquinolones in bacterial conjunctivitis","volume":"15","author":"Silverstein","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R14-20260416","first-page":"272","article-title":"Antibiotic resistance among ocular pathogens in the United States: Five-year results from the ARMOR study","volume":"138","author":"Asbell","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R15-20260416","first-page":"367","article-title":"Clinical guidelines for the management of acute conjunctivitis","volume":"105","author":"Epling","year":"2022","journal-title":"Am Fam Physician"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1757_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:49Z","timestamp":1786647469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1757_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_1757_25","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}